Compare EBON & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBON | COSM |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5M | 18.9M |
| IPO Year | 2020 | 2013 |
| Metric | EBON | COSM |
|---|---|---|
| Price | $2.38 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.3K | ★ 1.4M |
| Earning Date | 08-15-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,337,066.00 | ★ $59,792,819.00 |
| Revenue This Year | N/A | $20.69 |
| Revenue Next Year | N/A | $53.10 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 104.28 | 6.69 |
| 52 Week Low | $2.67 | $0.28 |
| 52 Week High | $5.99 | $1.32 |
| Indicator | EBON | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 21.71 | 36.68 |
| Support Level | $2.96 | $0.44 |
| Resistance Level | $3.27 | $0.50 |
| Average True Range (ATR) | 0.22 | 0.05 |
| MACD | -0.07 | -0.00 |
| Stochastic Oscillator | 3.34 | 0.00 |
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.